Bioenvision
Engages in the acquisition, development and marketing of compounds and technologies primarily for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$345m (Public information from May 2007)
New York City New York (HQ)
Authorizing premium user...